Anti-inflammatory oral drug colchicine improved COVID-19 outcomes for patients with relatively mild cases, according to certain topline results from the COLCORONA trial announced in a brief press release. But some find science-by-press-release troubling.
Fonte: Colchicine for Early COVID-19? Trial May Support Oral Therapy at Home | MedPage Today